Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?

Bone

Volumn 32, Issue 1, 2003, Pages 8-14

  Tanko L B ^a   Bagger, Y Z ^a   Nielsen, S B ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Bone markers; Cholesterol; Longitudinal study; Postmenopausal women; Risk factors; Trabecular bone loss

Indexed keywords

OSTEOCALCIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE DEVELOPMENT; BONE TURNOVER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; FOREARM; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MEASUREMENT; NORMAL HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; POSTMENOPAUSE; RISK FACTOR;

EID: 0037262545     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00918-3     Document Type: Article

References (26)

1. Hill K. The demography of menopause. Maturitas. 23:1996;113-127.
2. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., Demer L.L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 17:1997;680-687.
3. Parhami F., Garfinkel A., Demer L.L. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol. 20:2000;2346-2348.
4. Parhami F., Tintut Y., Beamer W.G., Gharavi N., Goodman W., Demer L.L. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Mineral Res. 16:2001;182-188.
5. Bartels T., Beitz J., Hein W., Schumann M., Laag L., Beitz A., Szymanski C., Mest H.J. [Changes in the spongiosa density in the femoral head of rabbits in atherosclerosis]. Beitr Orthop Traumatol. 37:1990;291-297.
6. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science. 286:1999;1946-1949.
7. Edwards C.J., Hart D.J., Spector T.D. Oral statins and increased bone-mineral density in postmenopausal women. Lancet. 355:2000;2218-2219.
8. Meier C.R., Schlienger R.G., Kraenzlin M.E., Schlegel B., Jick H. HMG-CoA reductase inhibitors and the risk of fractures. J Am Med Assoc. 283:2000;3205-3210.
9. Adami S., Braga V., Guidi G., Gatti D., Gerardi D., Fracassi E. Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res. 15:2000;599-604.
10. Rossouw J.E. Hormone replacement therapy and cardiovascular disease. Curr Opin Lipidol. 10:1999;429-434.
11. Christgau S., Rosenquist C., Alexandersen P., Bjarnason N.H., Ravn P., Fledelius C., Herling C., Qvist P., Christiansen C. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem. 44:1998;2290-2300.
12. Rosenquist C., Qvist P., Bjarnason N., Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem. 41:1995;1439-1445.
13. Broulik P.D., Kapitola J. Interrelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women. Endocr Reg. 27:1993;57-60.
14. Chan M.H., Mak T.W., Chiu R.W., Chow C.C., Chan I.H., Lam C.W. Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia. J Clin Endocrinol Metab. 86:2001;4556-4559.
15. Recker R., Lappe J., Davies K., Heaney R. Characterization of perimenopausal bone loss a prospective study. J Bone Miner Res. 15:2000;1965-1973.
16. Geusens P., Dequeker J., Verstraeten A., Nijs J. Age-, sex-, and menopause-related changes of vertebral and peripheral bone population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med. 27:1986;1540-1549.
17. Okano H., Mizunuma H., Soda M., Kagami I., Miyamoto S., Ohsawa M., Ibuki Y., Shiraki M., Suzuki T., Shibata H. The long-term effect of menopause on postmenopausal bone loss in Japanese women results from a prospective study. J Bone Miner Res. 13:1998;303-309.
18. Hansen M.A., Overgaard K., Christiansen C. Spontaneous postmenopausal bone loss in different skeletal areas - followed up for 15 years. J Bone Miner Res. 10:1995;205-210.
19. Marslew U., Overgaard K., Riis B.J., Christiansen C. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol. 79:1992;202-210.
20. Cosman F., Nieves J., Walliser J., Lindsay R. Postmenopausal osteoporosis patient choices and outcomes. Maturitas. 22:1995;137-143.
21. Akahoshi M., Soda M., Nakashima E., Tsuruta M., Ichimaru S., Seto S., Yano K. Effects of age at menopause on serum cholesterol, body mass index, and blood pressure. Atherosclerosis. 156:2001;157-163.
22. Wilson P.W., Anderson K.M., Harris T., Kannel W.B., Castelli W.P. Determinants of change in total cholesterol and HDL-C with age the Framingham Study. J Gerontol. 49:1994;M252-257.
23. van Beresteijn E.C., Korevaar J.C., Huijbregts P.C., Schouten E.G., Burema J., Kok F.J. Perimenopausal increase in serum cholesterol a 10-year longitudinal study. Am J Epidemiol. 137:1993;383-392.
24. Ferrara A., Barrett-Connor E., Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation. 96:1997;37-43.
25. Avioli L.V. Hormonal alterations and osteoporotic syndromes. J Bone Miner Res. 8:(Suppl 2):1993;S511-514.
26. Folsom A.R., McGovern P.G., Nabulsi A.A., Shahar E., Kahn E.S., Winkhart S.P., White A.D. Atherosclerosis Risk in Communities Study. Am Heart J. 132:1996;952-958.